Oligonucleotide Testing Market - Current Trends and Growth Opportunities till 2024

28 November 2018, The global Oligonucleotide Testing Market to reach USD 1,746.52 million by 2024, owing to the increasing research and development activities in the field of oligonucleotide. For instance, nowadays, multifunctional oligonucleotide based aptamer molecules are widely studied biomedical class among scientists across the globe. Due to its unique chemistry and potential advantages compared to currently available drugs (i.e. antibodies), aptamer became one of the most budding market for the future period.

With the rising concept of oligonucleotide as diagnostic, research and therapeutic agent, it is noticed that companies investigating the potential of oligonucleotide is going up. Number of small companies or start-ups entering the market is continuously increasing due to its potential advantages. Over the past few years, there has been explosive growth in number of research article published in the area of oligonucleotide and its products.

Browse Details of Report @ https://www.hexaresearch.com/research-report/oligonucleotide-testing-market

According to the open access journal Multidisciplinary Digital Publishing Institute (MDPI AG), in 1995, there were not more than 200 research articles on aptamers. Compare to this, now it is around 1800 research literatures published by scientist on aptamer assays or therapeutics. This number indicates that companies focusing on the oligonucleotide drugs is rising every year. This fact would in turn cause a surge in demand for oligonucleotide testing services, augmenting growth. However, strict regulatory framework is anticipated to hamper the market expansion to some extent.

Types segment is categorized into Instrument, Software, and Services. Among which, instrument segment captured the largest share of the total market. Introduction of technological advanced chromatographic columns coupled with increasing demand for oligonucleotide synthesis drive the segment growth. Instrument segment is further divided into liquid chromatography, mass chromatography and capillary electrophoresis. In terms of application, the market is segmented as research and commercial. Research segment capture the largest share owing to the strong product pipeline.

In 2016, North America dominated the market contributing a share of more than 40% in the revenue generated worldwide. The primary reason being the high growth of this region, particularly in the U.S. is the rising research and development activities on oligonucleotides. Asia pacific region was estimated to be the fastest growing region in the global market and is anticipated to grow at a CAGR of about 10.8% by 2024. The growing need for effective therapeutics, rising awareness level, coupled with the favorable government initiatives are expected to drive growth in this region.

Currently there are very less approved oligonucleotide drugs namely fomivirsen (Vitravene), pegaptanib (Macugen), and mipomersen (Kynamro). Of which mipomersen and fomivirsen acti through RNase H mediated cleavage of targeted RNA. These drugs were developed by Ionis Pharmaceuticals. As the number of drugs available in the market are less, the oligonucleotide pipeline is strong and is expected to show positive response over the projection period.

Technological advances in development of oligonucleotide products has been one of the major market driver. Oligonucleotide synthesis has undergone tremendous changes which has resulted in rapid synthesis and cost-effective techniques of oligomer synthesis. Improvement of synthesis methods which include high throughput synthesizers, better coupling reagents and new sets of protective amino groups has drastically changed the nucleotide synthesis chemistry. With rapid development in oligonucleotide synthesis, the testing market is also expected to show lucrative growth. The major players are focusing on quality, service and innovation and adopting strategies such as product portfolio expansion, capacity expansions, and development of new facilities to gain market share.

Hexa Research has segmented the global oligonucleotide testing market report based on product type, application and region:

Segmentation by Type, 2014 - 2024
    • Instrument
        • Liquid Chromatography
        • Mass Chromatography
        • Capillary Electrophoresis
    • Software
    • Service

Segmentation by application, 2014 - 2024
    • Research
    • Commercial

Segmentation by region, 2014 - 2024
    • North America
        • U.S.
    • Europe
        • Germany
        • UK
    • Asia Pacific
        • China
        • India
    • Rest of the world (RoW)

Key players analyzed:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Integrated DNA Technologies, Inc.
    • Agilent Technologies
    • Bruker

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Herbal Medicine Market Size and Regional Outlook, 2024

22 November 2018 -

The global Herbal Medicine Market is expected to reach USD 117.02 billion by 2024, driven by rising popularity of herbal therapeutics compared to conventional drugs. The market for herbal medicines and remedies is anticipated to record profitable growth due to their cost-effectiveness as compared to allopathic ones.

In 2016, Europe was the largest market for traditional medicines, contributing to 40.8% of the share and is expected to retain its leadership during the forecast period due to shifting from conventional drugs to herbal products. Fewer side effects and low toxicity compared to allopathy products are expected to provide a competitive advantage over other medicines in the market. Additionally, ready acceptance of herbal products owing to its benefits is the key factor for market growth and is expected to play a significant role in future.

Increased preference of complementary and alternative medicine (CAM) among others has resulted in the growth of herbal medicines in Asia Pacific. Asia Pacific is expected to record the fastest CAGR of 6.8% over the forecast period. Furthermore, Europe is anticipated to generate maximum revenue over the forecast period due to increasing awareness created by various associations such as Association for Natural Medicine in Europe (AIME).

Browse Details of Report @ https://www.hexaresearch.com/research-report/global-herbal-medicine-market

Concerning product segment, tablets & capsules are expected to witness the fastest growth owing to increasing acceptance of tablets over extracts and powders. Furthermore, properties such as high dose accuracy essential for optimum therapeutic effect will, in turn, promote the herbalism market growth. The extracts segment is expected to grow at a lucrative rate as they show an immediate therapeutic effect on administration.

For instance, in geriatric patients, extracts and other liquid dosage forms are preferred for administration as tablets show delayed therapeutic effect. Furthermore, extracts provide high potency as they possess only the active ingredients and no fillers which are present in tablets & capsules.

The rigorous focus on developing better extraction and purification techniques by herbal medicine manufacturers is expected to fuel the market. Furthermore, respective governments are also introducing several strategies to promote the uptake of herbal medicine market. For instance, in July 2017, the Chinese Ministry of Science and Technology invested USD 12.5 million for development of herbal treatments for the treatment of cancer and HIV/AIDS.

Hexa Research has segmented the global herbal medicine market based on Product, Indication, and region:

Segmentation by Product, 2014 - 2024 (USD Billion)
• Tablets & Capsules
• Powders
• Extracts
• Others

Segmentation by Indication, 2014 - 2024 (USD Billion)
• Digestive Disorders
• Respiratory Disorders
• Blood Disorders
• Others

Segmentation by Region, 2014 - 2024 (USD Billion)
• North America
    • U.S.
• Europe
    • Germany
• Asia Pacific
    • China
    • India
• Central & South America
• Middle East and Africa

Key Players Analyzed
• TSUMURA & CO.
• Dr. Willmar Schwabe India Pvt. Ltd.
• Blackmores
• NATURE'S ANSWER
• Arkopharma
• Arizona Natural Products
• Herbal Africa
• Bio Botanica, Inc.
• Sidomuncul
• Nature Herbs

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website: https://www.hexaresearch.com

US Wound Dressing Market Size to Reach USD 4.25 Billion By 2024

12 November 2018 -

The US Wound Dressing Market size is expected to reach USD 4.25 billion by 2024. Growing aging population and cases of diabetes and obesity are the major factors driving the market. Furthermore, increasing incidence of pressure ulcers in bedridden, wheelchair-bound, and/or physically impaired patients is expected to fuel the demand for wound care over the forecast period. For instance, annually, 2.5 million individuals suffer from pressure ulcer in U.S. and around USD 9.1 billion to USD 11.6 billion are spent for its treatment.

Moreover, growing cases of surgical procedures due to high incidence of wound infections and diabetic foot are expected to boost the demand for wound dressing. This has also increased the preference for advanced wound care products over simple dressing. Advanced dressing offers rapid healing, reasonable cost, with minimal inconvenience to the patient. However, owing to the demand for low cost dressing, traditional methods are being used to some extent. This may have a negative impact on the market development over the forecast period.

However, availability of various insurance schemes in U.S. for affordable medical care over long term, coupled with rise in consumer disposable income, is encouraging people to opt for advanced healthcare. This is anticipated to contribute to market expansion over the years to come.

Browse Details of Report @ https://www.hexaresearch.com/research-report/us-wound-dressing-market

The advanced dressing technique is the fastest-growing segment expanding at a CAGR of 4.4% over the forecast period. It also held the dominant market share of USD 1.8 billion in 2017. It is expected to reach USD 2.6 billion by 2024. Advanced dressings includes moist, antimicrobial, and active dressings. Factors such as rapid healing and minimal patient inconvenience are anticipated impel this growth over the forecast period.

Chronic and non-healing wounds are best treated with advanced wound dressing products. Limitations of traditional wound care have propelled the growth of the segment. Advanced moist wound care is recommended for chronic wounds like pressure and diabetic ulcers, burn injuries, and other slow-healing wounds. Advanced foam technique is essential to prevent and heal the exudation of burn injuries. All these factors are projected to propel the growth of the U.S. wound dressing market during the forecast period.

Advanced alginate dressing is recommended in highly exuding wounds, as it forms a gel around the wound bed and helps in keeping them dry and clean. Advanced alginate dressing have gel-forming ability and they also help reduce the pain. As a result, they are widely used for the treatment for bleeding wounds. Advanced films provide healing to semi-dry and dry wounds. Advanced hydrocolloid dressing helps protect the wound internally, as well as externally. Increasing number of surgeries is expected to fuel the growth of hydrogel dressings. All these factors are expected to propel the growth of the wound dressing market over the forecast period.

Antimicrobial dressings are easy to use, accessible without prescription, and less risk of resistant. Silver and non-silver are the two types of this dressings. Silver shows broad spectrum antibacterial activity and minimal toxicity towards host cells. The non-sliver wound dressing may have single or combination of various ingredients, such as iodine, chlorhexidine, Polyhexamethylbuguanide (PHMB), honey, acetic acid, and potassium permanganate. This type of dressing is used for faster healing process and for reducing the pain. Active wound dressings are administered for the repair and healing through bioactive and skin-substitute compounds. They are highly beneficial in healing chronic moist wounds.

Hexa Research has segmented the U.S. wound dressing market report based on product:-

Segmentation by Product Type, 2013 - 2024
    • Traditional
    • Advanced
        • Moist
            • Foam
            • Alginate
            • Films
            • Hydrocolloids
            • Hydrogel
        • Antimicrobial
            • Silver
            • Non-silver
        • Active
            • Biomaterials
            • Skin-substitute

Key Players Analyzed:
    • 3M Healthcare
    • Coloplast
    • Medline Industries
    • HARTMANN.
    • BSN Medical
    • Medtronic Plc
    • Smith & Nephew
    • ConvaTec
    • Derma Sciences
    • Systagenix

 Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website: https://www.hexaresearch.com

Probiotics Market Size, Share, Analysis and Trends Report, 2024

11 October 2018 - The global Probiotics Market size is expected to reach USD 66.03 billion by 2024. Demand for probiotic foods and beverages and animal feed is expected to keep the market buoyant in the forthcoming years. As functional ingredients, probiotics are used in cheese, milk, juices, cereals, nutrition bars, and infant formula.

Within the probiotics food and beverages segment, dairy products command major share. Yoghurt and yogurt-based beverages are the most commonly consumed probiotic dairy products. On the other hand, demand for probiotic animal feed is expected to gain strength with rising need to enhance animal immunity and yield.

According to the National Institute of Allergy and Infectious Diseases (NIAID), prolonged consumption of probiotics containing Bifidobacterium and Lactobacillus strains helps in the treatment of cold and flu. Research studies have revealed that probiotics help cure ill health effects through mechanisms such as immunomodulation.

Probiotics help in treating diseases such as intestinal inflammation, urogenital infections, and diarrhea. There are reported cases of deaths due to intestinal inflammation and other Irritable Bowel Diseases (IBD), such as Crohn's disease and ulcerative colitis. As there is a high prevalence of functional and organic gastrointestinal (GI) diseases in U.S. and European countries, these markets have a relatively high penetration of probiotics products compared to Asia Pacific. 

According to a study publish in the Journal of Crohn's and Colitis in 2016, increased mortality due to Crohn’s disease and Ulcerative Colitis was observed in Finland. The rise in reported deaths was due to the inflammation of gut.

Browse Details of Report @ https://www.hexaresearch.com/research-report/probiotics-market

Hectic work schedule and fluctuating diet patterns lead to various health problems such as constipation and ulcers. Changing lifestyle and increased consumption of sodium rich foods can cause gut infection. Probiotics help in restricting the growth of bad bacteria and enhancing immunity by improving gut health.

High prevalence of digestive disorders in U.S. and European countries have benefitted the demand in global probiotics market. Consumer inclination towards functional food and beverages is expected to increase the demand in near future. Also, rising awareness about effectiveness of probiotics in enhancing immunity is expected to benefit the global market. Countries such as China, Brazil, and India among others are making significant investments in probiotic products.

The global probiotics market is highly competitive. Companies operating in this market focus more on R&D activities to develop new products. Novel applications are developed by companies to strengthen their presence on global scale. Companies are also entering into partnerships with local players to increase their products penetration and geographical reach.

For instance, in September 2016, BioGaia signed an exclusive distributor agreement with Phillips Pharma Group for selling the rights of BioGaia ProTectis drops, tablets, and Oral Rehydration Solution (ORS) in Ghana, Nigeria, and Kenya. Besides, companies are focusing on building their brand image and raising awareness regarding probiotics usage in the Asia Pacific region.

Chr. Hansen Holding A/S is a prominent player that provides specialty ingredients for life science and food industries. The company produces probiotics under its food cultures and enzymes business division. Its probiotic products are used as ingredients in dietary supplements and food and beverages. The company is one of the leading suppliers of scientifically documented probiotic strains for dietary supplements and infant formula.

Some of the key companies in the market include Arla Foods, Inc.; BioGaia AB; Danone; Danisco A/S; General Mills, Inc.; I-Health Inc.; Lallemand Inc.; Lifeway Foods Inc.; and Mother Dairy Fruit & Vegetable Pvt. Ltd.

Hexa Research has segmented the global probiotics market report based on application, end-use and region:-

Segmentation by Application
    • Probiotic Food and Beverages
    • Probiotic Dietary Supplements
    • Animal Feed Probiotics

Segmentation by End-use
    • Human
    • Animal

Segmentation by Region
    • North America
    • Europe
    • Asia Pacific
    • Central & South America
    • Middle East & Africa

Key players analyzed:
    • Arla Foods, Inc.
    • BioGaia AB
    • Chr. Hansen Holding A/S
    • Danone
    • Danisco A/S
    • General Mills, Inc.
    • I-Health Inc.
    • Lallemand Inc.
    • Lifeway Foods Inc.

    • Mother Dairy Fruit & Vegetable Pvt. Ltd

Browse Related Category Market Reports@ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

China Scar Treatment Market Analysis and Industry Growth Report, 2025

25 September 2018 -

The China Scar Treatment Market size is expected to reach USD 2.77 billion by 2025 owing to the increasing emphasis on appearance. In the current scenario, all demographic segments of the population lay great importance on enhancing their esthetic appeal. In addition, unsightly scars often cause a huge impact on a person’s quality of life. Scar treatment helps in achieving complete skin rejuvenation, which improves the esthetic appeal of a person.

Rising number of road accidents is considered to be one of the high-impact rendering factors for boosting the demand for scar treatment products. Moreover, increased number of cases of hypertrophic burn scars, wherein the victim’s appearance is distorted, has also resulted in high demand for scar treatment products in China.

China scar treatment market is witnessing considerable technological developments with the introduction of laser therapies. Moreover, plastic and reconstructive surgeries are one of the trending procedures adopted commonly to enhance esthetic appeal. These surgeries help remove various types of scars, which, in turn, rejuvenates the skin.

Browse Details of Report @ https://www.hexaresearch.com/research-report/china-scar-treatment-market

Topical products accounted for the largest market revenue share as they are available as Over-The-Counter (OTC) products, which enables self-care and provides an easy and inexpensive way of scar treatment. With increasing awareness among populations about scar treatment options, the use of topical products has been on the rise.

The laser products are anticipated to witness the highest growth over the projected period as they are an effective and painless approach of scar treatment. Furthermore, technological advancements have significantly fueled the demand for laser treatments to effectively reduce and remove scars. Hence, laser scar removal has evolved as an innovative approach in the field of scar treatment.

In terms of scar type, atrophic scars observed the highest growth owing to the increasing cases of acne scars. A majority of the population deals with acne as a common problem. Moreover, these scars are easily treated with OTC products like creams and gels and the treatment is easy and effective. Thus, increasing the demand for topical products would drive the scar treatment market.

Moreover, hypertrophic and keloid scars are expected to witness a significant growth over the projected period. These scars are a result of injuries and wounds caused mostly due to body piercings, burn injuries, road accidents, and cuts. Growing cases of contracture scars, caused by burn injuries of second and third degree, have resulted in an increased demand for skin treatment products over the past few years.

Hospitals accounted for the largest market share among the end-use segments owing to the availability of various treatment options for scars. Hospitals offer a generalized treatment for majority of the emergency care services and further provide care during the recovery period. Moreover, majority of the population in China prefers hospitals over clinics and OTC medicines for basic care, which is also expected to augment the segment growth.

Furthermore, retail pharmacies/e-commerce segment is expected to witness the highest growth due to the convenience offered by these retail stores.

Hexa Research has segmented the China scar treatment market report based on product, scar type and end use
Segmentation by Product

• Topical Products
• Creams
• Gels
• Silicon sheets
• Others
• Laser Products
• CO2 Laser
• Pulse-dyed Laser
• Others
• Injectables
• Others

Segmentation by Scar Type

• Atrophic scars
• Hypertrophic & Keloid scars
• Contracture scars
• Stretch Marks

Segmentation by End Use

• Hospitals
• Clinics
• Retail pharmacies/E-commerce

Key players analyzed:

• Smith & Nephew PLC
• LUMENIS
• Sonoma Pharmaceuticals, Inc.
• Molnlycke Health Care
• Cynosure, Inc.
• NewMedical Technology, Inc.
• Suneva Medical, Inc.
• Pacific World Corporation
• Perrigo Company PLC 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website: https://www.hexaresearch.com

Global Healthcare BPO Market is Predicted to Witness High CAGR till 2025

The global Healthcare BPO Market size is expected to witness high growth over the forecast period. Increasing need to reduce operational costs is anticipated drive the market. The business process outsourcing (BPO) model has several advantages such as easy availability of skilled labor, low rates, and reduced training costs. Through outsourcing, medical organizations can concentrate on their core competencies and reduce their efforts and investments on support activities. These factors are driving the adoption of BPO in the medical sector.

High prevalence of various diseases has increased workload of medical institutions. Through adoption of outsourcing solutions, these organizations are able to focus on their core activity to maintain quality of service. Outsourcing services assist organizations in different supporting activities such as accounting, medical transcriptions, and patient database maintenance among others. Collaborations with third party healthcare BPO vendors for these activities is a rising industry trend.

Adoption of business strategies such as alignment of major resources towards core competencies is projected to drive the market over the forecast period. Cost cutting through outsourcing business model is anticipated to further augment the market in near future.

Browse Details of Report @ https://www.hexaresearch.com/research-report/healthcare-bpo-market

Costs of medical services have increased significantly over the last few years. Developing countries such as India, Philippines, and China offer skilled labour at low costs. As a result, companies are able to reduce overall cost by delegating work to vendors located in these regions. This factor is anticipated to positively influence the market over the forecast period. Offshore vendors handle activities such as medical billing, accounting, payroll, medical transcription, and coding.

Hospitals in the U.S. maintain a patient database used by insurance organisations for authentication. Database management and analysis are the key activities requiring professionals with adequate interpretation skills. Staff recruitment for such activities turns out to be a costly affair. Hence, hospitals find it easy to partner up with service providers located at distant locations.

However, risks associated with this business model are major restraints hampering overall growth of the healthcare BPO market. Data security is a growing concern owing to high risk of confidential patient data getting misused. Further, most outsourcing establishments are present in Asia Pacific. This makes coordinating in different time zones a challenge for both parties. Moreover, delays in rendering services on account of these factors are the reason why some organisations prefer in-house activities.

A remarkable rise in adoption of advanced technology in the medical and pharmaceutical sectors is anticipated to boost the growth of the global market for healthcare BPO in the forthcoming years. Hospitals have adopted enterprise resource planning (ERP) systems for crowd control and management. Digitization of various supportive medical activities is poised to bode well for demand in near future.

Moreover, government initiatives to reduce service cost is facilitating the need for outsourcing owing to its cost reduction ability. For instance, in 2012, the U.S Supreme Court upheld the main elements of President’s Patient Protection and Affordable Care Act. As per this act, it is mandatory for all American citizens to buy a health coverage. Further, this act is aimed at expanding medical coverage and providing better care along with reduced wasteful spending. The mandate has forced hospitals to focus on their core functions and cut costs by choosing third party sub-contractors for non-core functions.

Pharmaceutical outsourcing, provider outsourcing, and payers outsourcing are the three major applications of healthcare BPO. Pharmaceutical subcontracting is one of the prominent applications in terms of global demand. Provider subcontracting deals with medical coding, billing, Human Resources (HR), and medical coding. Payers segment deals with handling tasks associated with payroll, finance, and accounts.

North America was the leading region in global market on account of highly developed healthcare sector and high in-house operational costs. Pharmaceutical companies in U.S take support of off-shore vendors to focus on research and development.

Asia Pacific is expected to witness significant growth over the forecast period owing to the overall development of medical science coupled with high prevalence of diseases. In addition, Europe is expected to showcase a steady CAGR in near future mainly on account of developed pharmaceutical sector, especially in France and Germany.

Africa and South America are projected to witness a slow expansion owing to sluggish growth of healthcare industry. Moreover, companies from developing economies prefer in-house activities. This factor is anticipated to hinder regional market growth to an extent. Leading countries where vendors have their operational centers are U.S, Mexico, Ireland, France, India, Philippines, China, Vietnam, South Africa and Argentina.

Key players operating in the healthcare BPO market are Cognizant Technologies; Accenture; Wipro Technologies; Tata Consultancy Services; Genpact; WNS; Hinduja Global; Boehringer Ingelheim; Charles River Laboratories; Covance Inc.; Infosys; Lonza Group; Xerox Corporation; HCL Technologies; Exlservice; Medusind; Catalent; GeBBS Healthcare Solutions; and Quintiles, Inc.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-it-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website: https://www.hexaresearch.com